User profiles for Roser Solans

Roser Solans

Medico
Verified email at vhebron.net
Cited by 8134

Primary Sjögren syndrome in Spain: clinical and immunologic expression in 1010 patients

M Ramos-Casals, R Solans, J Rosas, MT Camps, A Gil… - Medicine, 2008 - journals.lww.com
We conducted the current study to characterize the clinical presentation of primary Sjögren
syndrome (SS) in a large cohort of Spanish patients and to determine whether epidemiologic, …

Salivary and lacrimal gland dysfunction (sicca syndrome) after radioiodine therapy

R Solans, JA Bosch, P Galofré, F Porta… - Journal of Nuclear …, 2001 - Soc Nuclear Med
Salivary gland dysfunction has been described in patients undergoing radioiodine therapy
but associated lacrimal gland dysfunction (sicca syndrome) has never been reported. We …

Systemic involvement in primary Sjögren's syndrome evaluated by the EULAR-SS disease activity index: analysis of 921 Spanish patients (GEAS-SS Registry)

M Ramos-Casals, P Brito-Zeron, R Solans… - …, 2014 - academic.oup.com
Objective. To evaluate systemic involvement in primary SS in a large cohort of Spanish
patients using the EULAR-SS disease activity index (ESSDAI) definitions. Methods. Systemic …

Influence of geolocation and ethnicity on the phenotypic expression of primary Sjögren's syndrome at diagnosis in 8310 patients: a cross-sectional study from the Big …

…, R Gerli, S Praprotnik, D Isenberg, R Solans… - Annals of the …, 2017 - ard.bmj.com
Objectives To analyse the influence of geolocation and ethnicity on the clinical presentation
of primary Sjögren's syndrome (SjS) at diagnosis. Methods The Big Data Sjögren Project …

[PDF][PDF] A large-scale genetic analysis reveals a strong contribution of the HLA class II region to giant cell arteritis susceptibility

…, S Prieto-González, R Solans… - The American Journal of …, 2015 - cell.com
We conducted a large-scale genetic analysis on giant cell arteritis (GCA), a polygenic
immune-mediated vasculitis. A case-control cohort, comprising 1,651 case subjects with GCA and …

How immunological profile drives clinical phenotype of primary Sjogren's syndrome at diagnosis: analysis of 10,500 patients (Sjogren Big Data Project)

…, D Sène, E Bartoloni, R Solans… - Clinical and …, 2018 - research.rug.nl
Objective. To evaluate the influence of the main immunological markers on the disease
phenotype at diagnosis in a large international cohort of patients with primary Sjogren's …

Central nervous system involvement of granulomatosis with polyangiitis: clinical–radiological presentation distinguishes different outcomes

…, P Kaminsky, A Le Quellec, F Maurier, R Solans… - …, 2015 - academic.oup.com
Objective. The aim of this study was to describe the presentation and outcomes of patients
with granulomatosis with polyangiitis (GPA) presenting with CNS involvement. Methods. …

Severe, life-threatening phenotype of primary Sjögren's syndrome: clinical characterisation and outcomes in 1580 patients (GEAS-SS Registry)

A Flores-Chávez, B Kostov, R Solans… - Clinical and …, 2018 - gredos.usal.es
[EN]To analyse the clinical features and outcomes of patients presenting with life-threatening
systemic disease in a large cohort of Spanish patients with primary Sjögren's syndrome (SS…

[PDF][PDF] A genome-wide association study identifies risk alleles in plasminogen and P4HA2 associated with giant cell arteritis

…, PA Monach, S Castañeda, R Solans… - The American Journal of …, 2017 - cell.com
Giant cell arteritis (GCA) is the most common form of vasculitis in individuals older than 50
years in Western countries. To shed light onto the genetic background influencing …

Systemic manifestations of primary Sjögren's syndrome out of the ESSDAI classification: prevalence and clinical relevance in a large international, multi-ethnic cohort …

…, R Gerli, A Sebastian, R Solans… - Clinical and …, 2019 - discovery.ucl.ac.uk
OBJECTIVES: To analyse the frequency and characterise the systemic presentation of primary
Sjögren’s syndrome (SS) out of the ESSDAI classification in a large international, multi-…